- Home
- KTTA vs ORIS Comparison
KTTA vs ORIS Comparison
Compare KTTA & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- ORIS
- Stock Information
- Founded
- KTTA 2020
- ORIS 2014
- Country
- KTTA United States
- ORIS China
- Employees
- KTTA N/A
- ORIS N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- KTTA Health Care
- ORIS Consumer Staples
- Exchange
- KTTA Nasdaq
- ORIS Nasdaq
- Market Cap
- KTTA 5.1M
- ORIS 5.3M
- IPO Year
- KTTA 2021
- ORIS 2024
- Fundamental
- Price
- KTTA $0.80
- ORIS $0.11
- Analyst Decision
- KTTA
- ORIS
- Analyst Count
- KTTA 0
- ORIS 0
- Target Price
- KTTA N/A
- ORIS N/A
- AVG Volume (30 Days)
- KTTA 171.7K
- ORIS 65.5M
- Earning Date
- KTTA 08-14-2025
- ORIS 01-01-0001
- Dividend Yield
- KTTA N/A
- ORIS N/A
- EPS Growth
- KTTA N/A
- ORIS N/A
- EPS
- KTTA N/A
- ORIS 0.17
- Revenue
- KTTA N/A
- ORIS $15,014,000.00
- Revenue This Year
- KTTA N/A
- ORIS N/A
- Revenue Next Year
- KTTA N/A
- ORIS N/A
- P/E Ratio
- KTTA N/A
- ORIS $0.69
- Revenue Growth
- KTTA N/A
- ORIS N/A
- 52 Week Low
- KTTA $0.65
- ORIS $0.08
- 52 Week High
- KTTA $7.50
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- KTTA 55.44
- ORIS 33.88
- Support Level
- KTTA $0.75
- ORIS $0.11
- Resistance Level
- KTTA $0.91
- ORIS $0.12
- Average True Range (ATR)
- KTTA 0.06
- ORIS 0.01
- MACD
- KTTA 0.02
- ORIS 0.02
- Stochastic Oscillator
- KTTA 52.10
- ORIS 33.79
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).